MRFRの分析によると、抗生物質耐性感染症治療の市場規模は2022年に45.39 (10億ドル)と推定されました。この市場は、2023年の47.95 (10 億ドル) から2032年までに78.6 (10 億ドル) に成長し、予測期間 (2024-2032) のCAGRは約5.64% になると予想されます。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY TYPE OF INFECTION (USD BILLION)
6.1. Skin Infections
6.2. Respiratory Infections
6.3. Urinary Tract Infections
6.4. Gastrointestinal Infections
7. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY PATHOGEN TYPE (USD BILLION)
7.1. Gram-Positive Bacteria
7.2. Gram-Negative Bacteria
7.3. Fungi
7.4. Viruses
8. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY TREATMENT METHOD (USD BILLION)
8.1. Antibiotic Therapy
8.2. Combination Therapy
8.3. Supportive Care
8.4. Surgical Intervention
9. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY END USER (USD BILLION)
9.1. Hospitals
9.2. Clinics
9.3. Homecare Settings
9.4. Pharmacies
10. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Antibiotic Resistant Infections Treatment Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Antibiotic Resistant Infections Treatment Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Gilead Sciences
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Johnson and Johnson
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Baxter International
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Teva Pharmaceutical Industries
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Roche
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. AbbVie
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Pfizer
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Novartis
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. GlaxoSmithKline
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Merck and Co
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. BristolMyers Squibb
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Amgen
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Eli Lilly and Company
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Sanofi
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. AstraZeneca
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 8. US ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 9. US ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 10. US ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 11. US ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 28. UK ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 29. UK ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 30. UK ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 31. UK ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 58. APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 59. APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 60. APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 61. APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 128. MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 129. MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 130. MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 131. MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF INFECTION, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATHOGEN TYPE, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS
FIGURE 3. US ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 4. US ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 5. US ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 6. US ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 7. US ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 9. CANADA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 10. CANADA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 11. CANADA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 12. CANADA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS
FIGURE 14. GERMANY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 15. GERMANY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 16. GERMANY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 17. GERMANY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 18. GERMANY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 20. UK ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 21. UK ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 22. UK ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 23. UK ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 25. FRANCE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 26. FRANCE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 27. FRANCE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 28. FRANCE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 30. RUSSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 31. RUSSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 32. RUSSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 33. RUSSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 35. ITALY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 36. ITALY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 37. ITALY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 38. ITALY ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 40. SPAIN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 41. SPAIN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 42. SPAIN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 43. SPAIN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 45. REST OF EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 46. REST OF EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 47. REST OF EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 48. REST OF EUROPE ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS
FIGURE 50. CHINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 51. CHINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 52. CHINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 53. CHINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 54. CHINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 56. INDIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 57. INDIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 58. INDIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 59. INDIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 61. JAPAN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 62. JAPAN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 63. JAPAN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 64. JAPAN ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 66. SOUTH KOREA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 67. SOUTH KOREA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 68. SOUTH KOREA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 69. SOUTH KOREA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 71. MALAYSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 72. MALAYSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 73. MALAYSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 74. MALAYSIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 76. THAILAND ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 77. THAILAND ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 78. THAILAND ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 79. THAILAND ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 81. INDONESIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 82. INDONESIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 83. INDONESIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 84. INDONESIA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 86. REST OF APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 87. REST OF APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 88. REST OF APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 89. REST OF APAC ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS
FIGURE 91. BRAZIL ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 92. BRAZIL ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 93. BRAZIL ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 94. BRAZIL ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 95. BRAZIL ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 97. MEXICO ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 98. MEXICO ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 99. MEXICO ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 100. MEXICO ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 102. ARGENTINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 103. ARGENTINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 104. ARGENTINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 105. ARGENTINA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 107. REST OF SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 108. REST OF SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 109. REST OF SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 110. REST OF SOUTH AMERICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 113. GCC COUNTRIES ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 114. GCC COUNTRIES ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 115. GCC COUNTRIES ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 116. GCC COUNTRIES ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 118. SOUTH AFRICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 119. SOUTH AFRICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 120. SOUTH AFRICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 121. SOUTH AFRICA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTION
FIGURE 123. REST OF MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGEN TYPE
FIGURE 124. REST OF MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 125. REST OF MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY END USER
FIGURE 126. REST OF MEA ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET
FIGURE 133. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY TYPE OF INFECTION, 2024 (% SHARE)
FIGURE 134. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY TYPE OF INFECTION, 2019 TO 2032 (USD Billions)
FIGURE 135. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY PATHOGEN TYPE, 2024 (% SHARE)
FIGURE 136. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY PATHOGEN TYPE, 2019 TO 2032 (USD Billions)
FIGURE 137. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY TREATMENT METHOD, 2024 (% SHARE)
FIGURE 138. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY TREATMENT METHOD, 2019 TO 2032 (USD Billions)
FIGURE 139. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY END USER, 2024 (% SHARE)
FIGURE 140. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY END USER, 2019 TO 2032 (USD Billions)
FIGURE 141. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. ANTIBIOTIC RESISTANT INFECTIONS TREATMENT MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
